Connect with us

Legal & Regulation

Attorney General in Barbados Pledges to Introduce a Medical Marijuana Bill in Parliament

Published

on

Attorney General in Barbados Pledges to Introduce a Medical Marijuana Bill in Parliament

Dale Marshall – the attorney General of Barbados – has promised to introduce a medical marijuana bill in parliament.

In a press conference, Marshall said that the Barbadian government is dedicated to rolling out a medical cannabis industry. However, he noted that the main challenge is appeasing critics who feel that this bill could lead to the legalization of recreational cannabis, which might affect the country’s diplomatic regulations with the U.S.

Marshal claimed that the powerful religious leaders of the Caribbean nation are not against the legalization of medical marijuana. However, the biggest issue is the feeling that if cannabis can be used for medical purposes, then it might as well be used for recreation, which the religious community is opposed to.

Making the statement, Marshall was keen to clarify that the government doesn’t have any intentions to legalize recreational marijuana. He said that Barbados is fully aware of its obligations according to the 1969 United Nations Convention, but then pointed out that it does not include what is normally considered as illegal narcotics if they are used for scientific or medical purposes.

The many Caribbean banks that have corresponding American banks will not accept money from the cannabis industry since it is illegal under the United States’ Federal law. This is the reason why many Caribbean countries have been reluctant to make marijuana legal despite its huge significance in the Rastafarian culture.

Nevertheless, the tide is progressively turning. Jamaica started exporting its legal marijuana to markets such as Canada, and is still trying to lobby the U.S. government to relax its banking laws.

In July, Saint Vincent & The Grenadines got its first cannabis cultivation licenses after bringing on board experts from Trinidad & Tobago. Many big Canadian companies are establishing their operations in the Caribbean, and this could soon become a hotspot in the global cannabis trade.

Marshall insisted that he isn’t troubled by Barbados lagging behind other Caribbean countries in the production of medical marijuana. He argued that it is good to get the framework right before taking the plunge.

Parliamentarians are expected to debate Marshall’s bill in August 30.

Joe personifies dedication in writing and when you read his unique, well-researched content this will become very clear. With a passion for social and environmental issues, and first-hand experience with over 40 years experience in business, finance, and marketing, we are honored to have his CBD and cannabis insights and contributions. Mr. Mielcarek is semi-retired, so he finds joy in digging deep to sift through the facts to deliver a well polished and professionally packaged article for readers to consume, digest and understand.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.